EUVIMEDEUVIMED entdecken
Open Access

PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition

Joanna Triscott iD, Matthias Reist iD, Lukas Küng iD, Francielle C Mosele iD, Marika Lehner, John Gallon iD, Archna Ravi, Gurpreet K Arora, Simone de Brot iD, Mark Lundquist iD, Hector Gallart-Ayala iD, Julijana Ivanisevic iD und 4 weitere

Science Advances · 2023

DOI: 10.1126/sciadv.ade8641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Joanna Triscott und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department for BioMedical Research, University of Bern, Bern 3008, Switzerland. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Receptors, Androgen. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphatidylinositol (PI)regulating enzymes are frequently altered in cancer and have become a focus for drug development. Here, we explore the phosphatidylinositol-5-phosphate 4-kinases (PI5P4K), a family of lipid kinases that regulate pools of intracellular PI, and demonstrate that the PI5P4Kα isoform influences androgen receptor (AR) signaling, which supports prostate cancer (PCa) cell survival. The regulation of PI becomes increasingly important in the setting of metabolic stress adaptation of PCa during androgen deprivation (AD), as we show that AD influences PI abundance and enhances intracellular pools of PI-4,5-P 2 . We suggest that this PI5P4Kα-AR relationship is mitigated through mTORC1 dysregulation and show that PI5P4Kα colocalizes to the lysosome, the intracellular site of mTORC1 complex activation. Notably, this relationship becomes prominent in mouse prostate tissue following surgical castration. Finally, multiple PCa cell models demonstrate marked survival vulnerability following stable PI5P4Kα inhibition. These results nominate PI5P4Kα as a target to disrupt PCa metabolic adaptation to castrate resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Neoplasms, Castration-ResistantReceptors, AndrogenAnimalsHumansMaleMiceAndrogen AntagonistsAndrogensCell Line, TumorMechanistic Target of Rapamycin Complex 1Signal TransductionPhosphotransferases (Alcohol Group Acceptor)

Substanzen

Androgen AntagonistsAndrogensMechanistic Target of Rapamycin Complex 1Receptors, AndrogenPIP4K2A protein, humanPhosphotransferases (Alcohol Group Acceptor)

Autor:innen und Institutionen

  • Department for BioMedical Research, University of Bern, Bern 3008, Switzerland.
  • Institute of Biosciences, São Paulo State University, São Paulo, Brazil.
  • Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Cell and Molecular Biology of Cancer Program, Sanford Burnham Prebys, La Jolla, CA 92037, USA.
  • COMPATH, Institute of Animal Pathology, University of Bern, Bern, Switzerland.
  • Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY 10065, USA.

ORCID-Profile: Joanna Triscott, Matthias Reist, Lukas Küng, Francielle C Mosele, John Gallon, Simone de Brot, Mark Lundquist, Hector Gallart-Ayala, Julijana Ivanisevic, Salvatore Piscuoglio, Lewis C Cantley, Brooke M Emerling, Mark A Rubin

Förderung

  • NCI NIH HHS

Zitieren

APA

Triscott, J., Reist, M., Küng, L., Mosele, F. C., Lehner, M., Gallon, J., Ravi, A., Arora, G. K., de Brot, S., Lundquist, M., Gallart-Ayala, H., Ivanisevic, J., Piscuoglio, S., Cantley, L. C., Emerling, B. M., & Rubin, M. A. (2023). PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition. Science Advances. https://doi.org/10.1126/sciadv.ade8641

Vancouver

Triscott J, Reist M, Küng L, Mosele FC, Lehner M, Gallon J, et al. PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition. Science Advances. 2023. doi:10.1126/sciadv.ade8641

BibTeX
@article{Triscott2023,
  author = {Triscott, Joanna and Reist, Matthias and Küng, Lukas and Mosele, Francielle C and Lehner, Marika and Gallon, John and Ravi, Archna and Arora, Gurpreet K and de Brot, Simone and Lundquist, Mark and Gallart-Ayala, Hector and Ivanisevic, Julijana and Piscuoglio, Salvatore and Cantley, Lewis C and Emerling, Brooke M and Rubin, Mark A},
  title = {PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition},
  journal = {Science Advances},
  year = {2023},
  doi = {10.1126/sciadv.ade8641}
}
Kostenlos starten →